Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
D-aminoacyl-tRNA deacylase 1 (DTD1) is an essential enzyme responsible for maintaining the fidelity of protein translation by hydrolyzing D-aminoacyl-tRNAs that are mistakenly charged by aminoacyl-tRNA synthetases[2][3][4]. It recognizes and deacylates tRNAs charged with D-amino acids, preventing their incorporation into proteins, which would be lethal or deleterious for cells[2]. DTD1 shows specificity for D-amino acids and also removes glycine mischarged onto tRNA(Ala), further ensuring accurate translation[1][4]. Structurally, it operates as a dimer with catalytic and chiral selection motifs that discriminate D- from L-amino acids[1][3]. Besides its role in translation quality control, DTD1 is implicated in DNA replication initiation via its DNA unwinding element-binding activity and possesses similarity to histidyl-tRNA synthetase[4]. Although targeted therapies or drugs are not yet associated with DTD1, its crucial role in translation fidelity makes it an attractive candidate for drug development against pathogens that rely on error-prone protein synthesis[2].
*Not applicable* (no known drugs)—the enzyme itself catalyzes hydrolysis of D-aminoacyl-tRNA ester bonds, thus rescuing cells from translation errors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-aminoacyl-tRNA deacylase 1 (DTD1).